Notably, this effect on the NFκB pathway was consistent between CRC cell lines despite heterogeneity of the lines, with respect to the profile of mutations in APC, β-catenin, p53 and DNA MMR genes (see Table 1). This evidence concerns the gene NFKB1 and colorectal carcinoma.